Xiang Xie
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor | Phase 4 | 2023-08-01 |
| Completed | Prognosis of Treated Acute Coronary Syndrome Patients: a Multicenter Study Acute Coronary Syndrome | — | 2016-06-01 |
| Completed | Cohort Study of Chronic Heart Failure Analyze Etiology, Comorbidities, Clinical Characteristics | — | 2012-11-20 |